TK006
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TK006, covering 2017-08-23 to 2018-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Safety Assessment of Repeated Administration of TK006 in Patients With Breast Cancer-related Bone Metastases [Phase 1]